关注
Dr. Malkiet kaur
Dr. Malkiet kaur
Assistant Professor, Mullana University
在 mmumullana.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Osteoblast-n-osteoclast: making headway to osteoporosis treatment
M Kaur, M Nagpal, M Singh
Current Drug Targets 21 (16), 1640-1651, 2020
382020
Chitosan-based polymer blends for drug delivery systems
M Kaur, A Sharma, V Puri, G Aggarwal, P Maman, K Huanbutta, M Nagpal, ...
Polymers 15 (9), 2028, 2023
282023
Antiviral essential oils incorporated in nanocarriers: Strategy for prevention from COVID-19 and future infectious pandemics
M Kaur, G Devi, M Nagpal, M Singh, GA Dhingra, G Aggarwal
Pharmaceutical nanotechnology 8 (6), 437-451, 2020
282020
Improved antibacterial activity of topical gel-based on nanosponge carrier of cinnamon oil
M Kaur, M Nagpal, M Singh, TG Singh, G Aggarwal, GA Dhingra
BioImpacts: BI 11 (1), 23, 2021
242021
Nanomaterials for skin antifungal therapy: An updated review
M Nagpal, M Kaur
Journal of Applied Pharmaceutical Science 11 (1), 015-025, 2021
152021
Role of nanotechnology in taste masking: recent updates
V Vishvakarma, M Kaur, M Nagpal, S Arora
Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 15 (1), 1-14, 2023
142023
Lock stock and barrel of wound healing
GA Dhingra, M Kaur, M Singh, G Aggarwal, M Nagpal
Current Pharmaceutical Design 25 (38), 4090-4107, 2019
102019
Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives
KPG Udesh Kaushal, Malkiet Kaur, Manju Nagpal, Madhusmita Bhuyan
Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 15 (1), 15-28, 2023
82023
Skin cancer management: current scenario and future perspectives
M Jindal, M Kaur, M Nagpal, M Singh, G Aggarwal, GA Dhingra
Current Drug Safety 18 (2), 143-158, 2023
62023
Air Pollution Tolerance Index (APTI): An important determinant for the development of green space in and around industrial/urban area
M Kaur, A Sharma, J Katnoria, A Nagpal
Bioremediation: Current research and application, 422-449, 2017
62017
Nanotechnology for targeted drug delivery to treat osteoporosis
M Kaur, M Nagpal, G Aggarwal
Current Drug Targets 24 (1), 2-12, 2023
52023
Recent avenues in treatment of liver diseases: role of nanotechnology
M Bhuyan, M Kaur, U Kaushal, M Nagpal, M Singh, G Aggarwal
Current Drug Targets 24 (4), 320-331, 2023
22023
Treatment of tuberculosis in nano era: recent avenues
R Rathi, M Nagpal, M Kaur, P Ballouria, R Dutta, G Aggarwal, S Arora
Current Bioactive Compounds 18 (7), 13-26, 2022
22022
Advanced dosage form design: Role of modified natural gums
G Devi, M Kaur, M Nagpal, A Sharma, V Puri, GA Dhingra, M Arora
Asian Journal of Chemistry, 2021
22021
Formulation and Characterization of Topical Gel of Cinnamon Oil Nanosponge Carriers
M Kaur, M Nagpal
Proceedings of International Conference on Drug Discovery (ICDD), 2020
22020
Development and Evaluation of Sulfobutylether-β-cyclodextrin Inclusion Complexes of Etoricoxib for Enhancing Dissolution
V Vishvakarma, M Kaur, M Nagpal, P Maman
Current Bioactive Compounds 20 (4), 70-81, 2024
12024
Molecular Complex of HSIM-loaded Polymeric Nanoparticles: Potential Carriers in Osteoporosis
M Kaur, M Nagpal, AK Grewal, S Chauhan, CP Dora, TG Singh
Current Drug Targets 24 (13), 1066-1078, 2023
12023
Development and Characterization of LBG-PVA Interpenetrating Networks Incorporating Gliclazide for Sustained Release
A Katoch, M Nagpal, M Kaur, M Singh, G Aggarwal, GA Dhingra
Current Drug Therapy 16 (1), 54-63, 2021
12021
Soluplus-based Polymeric Micelles: A Promising Carrier System for Challenging Drugs
MN Malkiet Kaur, Ankit Rathee, Vrinda Krishna
International Journal of Pharmaceutical Sciences Research and Reviews 84 (9 …, 2024
2024
Soluplus-based Polymeric Micelles: A Promising Carrier System for Challenging Drugs
MN Malkiet Kaur, Ankit Rathee, Vrinda Krishna
International Journal of Pharmaceutical Sciences Review and Research 84 (9 …, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20